Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FS069 data

Animal data with the San Diego company's second-generation ultrasound contrast agent, FS069, were presented at

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE